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Summary 
CD4+ T cells comprise effector and regulatory subsets, which exhibit unique functions and 
properties and protect against different pathogens. Several molecular cues that define the 
differentiation into the distinct T cell subsets have already been identified. One determinant is 
the RNA-binding protein Roquin that post-transcriptionally regulates gene expression and 
prevents autoimmunity. It is therefore crucial to precisely understand how Roquin controls 
CD4+ T cell fate decisions on the molecular level. In this thesis, we proved that Roquin acts 
on different layers of regulation to direct T cell differentiation. On the one hand by 
destabilizing but also by inhibiting the translation of its mRNA targets, and on the other hand 
by suppressing the PI3K-mTOR signaling pathway. In publication I, we investigated whether 
translational regulation is a further post-transcriptional mechanism by which Roquin controls 
its targets. By performing PAR-CLIP, mRNA sequencing and ribosome profiling on MEF 
cells, we globally determined that Roquin does not only reduce the stability of its mRNA 
targets, but also, at least for a smaller subset, inhibits their translation. These data sets also 
enabled us to identify a new linear binding element (LBE) of Roquin that is highly abundant in 
its targets and is recognized by its ROQ and Znf domains. Furthermore, we revealed that 
Roquin-mediated translational regulation of its targets depends on the number of binding 
sites in their 3' untranslated regions (UTRs). Among the translationally-repressed Roquin 
targets we found the T cell relevant genes Nfat5 and Nfkbid. Through further analysis of the 
3' UTR of Nfkbid we have identified a minimal response element, which consists of six stem 
loop structures and is indispensable for its post-transcriptional regulation by Roquin. In 
publication II we examined the function of Roquin in Treg cells by analyzing mice, which 
lacked Roquin expression specifically in these cells. We found that Roquin-deficient Treg 
cells are dysfunctional and failed to inhibit the induction of colitis in a T cell transfer model. 
Furthermore, we observed that they lose the expression of the IL-2 receptor α chain (CD25) 
and adopt a functional follicular Treg (Tfr) phenotype. Mechanistically, we elucidated that 
Roquin suppresses the PI3K-Akt-mTOR-Foxo1 signaling pathway in Treg and conventional T 
cells by controlling two novel Roquin-targeted mRNAs, the PI3K antagonist Pten and the 
Foxo1-specific E3 ubiquitin ligase Itch. Roquin interferes with miR-17~92 binding to an 
overlapping cis-element in the PTEN 3' UTR thereby upregulating Pten expression. In 
addition, it represses Itch expression leading to increased levels and nuclear localization of 
Foxo1. Finally, we showed that inhibition of PI3K or mTOR rectifies the aberrant frequencies 
of Roquin-deficient Th17 and iTreg cells in vitro and Tfh cells in vivo. My contribution to these 
two studies was to globally define a Roquin-bound mRNA set and its mode of post-
transcriptional repression. These investigations also enabled me to elucidate Roquin-
mediated regulation of the PI3K-mTOR signaling pathway, thereby controlling Treg cell 
function and differentiation of T helper cells. 
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Zusammenfassung 
CD4+ T Zellen umfassen Effektor- und regulatorische Untergruppen mit spezifischen 
Funktionen und Eigenschaften, die vor Infektionen mit Pathogenen schützen. Zahlreiche 
molekulare Signale, die die Differenzierung in die unterschiedlichen T-Zell-Untergruppen 
steuern, wurden bereits identifiziert. Das RNA-bindende Protein Roquin ist einer dieser 
entscheidenden Faktoren, der die Genexpression post-transkriptionell reguliert und die 
Entstehung von Autoimmunerkrankungen verhindert. Deshalb ist es entscheidend, ein 
genaues Verständnis darüber zu erlangen, wie Roquin Schicksalsentscheidungen von CD4+ 
T Zellen auf molekularer Ebene kontrolliert. In der vorliegenden Arbeit haben wir bewiesen, 
dass Roquin auf verschiedenen regulatorischen Ebenen T-Zell-Differenzierung lenkt, zum 
einen, indem es sowohl die Stabilität als auch die Translation seiner mRNA Zielmolekülen 
verringert, und zum anderen durch Hemmung des PI3K-mTOR Signalwegs. In Publikation I 
haben wir untersucht, ob translationale Regulation einen weiteren post-transkriptionellen 
Mechanismus darstellt, durch den Roquin seine Zielmoleküle kontrolliert. Mit Hilfe der 
Methoden PAR-CLIP, mRNA Sequenzierung und Ribosome Profiling konnten wir global in 
MEF Zellen feststellen, dass Roquin nicht nur die Stabilität seiner mRNA Zielmoleküle senkt, 
sondern auch die Translation einiger weniger Zielmolekülen hemmt. Diese Datensätze 
ermöglichten es uns zudem, ein neues lineares Bindungselement (LBE) von Roquin zu 
identifizieren, das in seinen Zielemolekülen sehr häufig vorkommt und von seinen ROQ und 
Znf Domänen erkannt wird. Weiterhin zeigten wir, dass die durch Roquin-vermittelte 
translationale Regulation seiner Zielmoleküle von der Anzahl der Bindungsstellen innerhalb 
ihrer 3' untranslatierten Region (UTR) abhängt. Unter den translational reprimierten mRNAs 
fanden wir die T-Zell relevanten Gene Nfkbid und Nfat5. Durch weitere Analysen des 
3' UTRs von Nfkbid haben wir ein minimales Response-Element identifiziert, das aus sechs 
Haarnadelstrukturen besteht und für die post-transkriptionelle Regulation durch Roquin 
notwendig ist. In Publikation II haben wir die Funktion von Roquin in Treg Zellen erforscht 
und dazu Mäuse untersucht, denen spezifisch in diesem Zelltyp die Expression von Roquin 
fehlt. Hier zeigte sich, dass Roquin-defiziente Treg Zellen dysfunktional sind und somit nicht 
in der Lage waren, das Einsetzen von Colitis in einem T Zell Transfer Modell zu verhindern. 
Weiterhin konnte beobachtet werden, dass diese Zellen die Expression der alpha-Kette des 
IL-2 Rezeptors (CD25) verlieren und einen funktionellen follikulären regulatorischen T Zell 
(Tfr) Phänotyp annehmen. Mechanistisch konnten wir zeigen, dass Roquin den PI3K-Akt-
mTOR-Foxo1 Signalweg in Treg und Effektor-T-Zellen hemmt, indem es zwei neue Roquin 
Zielmoleküle, den PI3K Antagonist Pten und die Foxo1-spezifische E3 Ubiquitin Ligase Itch, 
kontrolliert. Roquin verhindert die Bindung von miR-17~92 an ein überlappendes cis-Element 
im 3' UTR von Pten, wodurch dessen Expression erhöht wird. Außerdem verringert Roquin 
die Expression von Itch, was zu einem höheren Proteinlevel und zur nuklearen Lokalisation 
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von Foxo1 führt. Abschließend zeigten wir, dass die Inhibierung von PI3K oder mTOR die 
abnormale Entstehung von Roquin-defizienten Th17 und iTreg Zellen in vitro, sowie die von 
Tfh Zellen in vivo, auf Wildtyp Niveau korrigiert. Mein Beitrag zu diesen zwei 
Veröffentlichungen war es, global alle Roquin-gebundenen mRNAs sowie ihre durch Roquin-
ausgelöste post-transkriptionelle Hemmung aufzuklären. Des Weiteren ermöglichten es mir 
diese Untersuchungen aufzudecken, dass Roquin den PI3K-mTOR Signalweg reguliert, um 
dadurch die Funktion und Differenzierung von Treg und T Helferzellen zu steuern.  
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List of abbreviations 
ADE Alternative decay element 
Ago Argonaute 
BCR B cell receptor 
CD Cluster of differentiation 
CD25 α-chain of the IL-2 receptor 
CDE Constitutive decay element 
DKO Double knockout  
Foxo1 Forkhead box O1 
GC Germinal center 
ICOS Inducible T cell co-stimulator  
IL Interleukin 
IFN-γ Interferon-gamma 
LBE Linear binding element 
MEF Mouse embryonic fibroblasts 
miRNA or miR microRNA 
mRNA messenger ribonucleic acid 
mTOR Mammalian target of rapamycin 
mTORC1/mTORC2 mTOR complex 1 or 2 
NFAT5 Nuclear factor of activated T cells 5 
PAR-CLIP Photoactivatable-Ribonucleoside-Enhanced Cross-linking and 
Immunoprecipitation 
PI3K Phosphatidylinositol-3-kinase 
Pten Phosphatase and tensin homologue 
RISC RNA-induced silencing complex 
SGK1 Serum- and glucocorticoid-induced protein kinase 1 
TCR T cell receptor 
Teff T effector cells 
TGF-β Transforming growth factor 
Th T helper 
Tfh Follicular T helper cells 
Tfr Follicular regulatory T cells 
TOP Terminal oligopyrimidine tract 
iTreg induced regulatory T cells 
tTreg thymic regulatory T cells 
UTR Untranslated region 
Znf Zinc finger 
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1 Introduction 
The immune system can be divided into two components, the innate and the adaptive 
immune system. Both are essential for combating various pathogens, but they differ in their 
function, specificity and complexity. The innate immune system forms the first protective 
barrier against pathogens. This type of immune reaction comprises the activation of 
macrophages, dendritic cells and natural killer cells and is triggered directly after the infection 
by the recognition of several conserved molecular structures of bacteria and viruses. 
Nevertheless, certain types of microbes and viruses are capable to evade these 
mechanisms. Therefore, the adaptive immune system with its immense diversity of antigen-
specific receptors is additionally activated and can eliminate the respective pathogens after a 
certain induction phase. The central cellular components herein are B and T lymphocytes, 
which recognize a broad variety of antigens via their B (BCR) and T cell receptor (TCR). B 
cells derive from the bone marrow and can differentiate into plasma cells, which produce 
large amounts of antibodies. T cells develop in the thymus where they differentiate into two 
different subsets: cytotoxic CD8+ T cells, which kill cells infected with viruses or intracellular 
pathogens, and CD4+ T cells. Basically, CD4+ T cells can also be subdivided into two groups. 
On the one hand, there are CD4+ T effector (Teff) cells like T helper (Th) cells including Th1, 
Th2, Th17 and follicular T helper (Tfh) cells, and on the other hand regulatory T cells. The 
latter can also be categorized into three subsets, thymus-derived Treg (tTreg), peripherally 
induced Treg (iTreg) and follicular regulatory T (Tfr) cells. The different CD4+ T cell subsets, 
with the exception of tTreg and Tfr cells, differentiate from naive CD4+ T cells upon TCR 
activation in an appropriate cytokine milieu. Each subset has distinct immunological 
functions, requires and secretes different cytokines and is characterized by specific 
transcription factors (Figure 1). The major function of Teff cells is to protect the organism 
from various infections, whereas Treg cells suppress self-reactive immune responses to 
prevent autoimmune diseases. In a healthy organism, Treg and Teff cells are in a balance to 
maintain self-tolerance and in parallel to avoid inflammations.  
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Figure 1 CD4+ T cell subsets. 
The different CD4+ T cells subsets including Th1, Th2, Th17, Tfh and iTreg cells 
differentiate from naive CD4+ T cells upon T cell activation in the presence of a different 
cytokine milieu. Tfr cells develop from thymus-derived Foxp3+ precursors. Each CD4+ T cell 
subset is characterized by specific transcription factors and secretes different types of 
interleukins (IL). 
 
However, when the differentiation of naive T cells into the different CD4+ T cell 
subsets is dysregulated and the balance between Treg and Teff cells is tilted towards a 
strong Teff response, this can lead to dysregulated and exaggerated immune responses, 
hence to severe autoimmune diseases. For this reason, it is of great importance for the 
organism to maintain the immune homeostasis, and that the naive T cells make the “right“ 
decision to become either a Treg or Teff cell. An arising question is what influences a T cell 
to make the “right” decision? There are several critical determinants that affect T cell fate 
decisions: environmental cues e.g. diet and stress, signal-induced ubiquitylation and protein 
degradation, epigenetics, TCR signal strength, transcription, post-transcriptional gene 
regulation, metabolism, and signaling pathways (Figure 2). The complex interplay between 
these factors and their sensitivity towards minor changes can lead to drastic effects on T cell 
homeostasis and function. 
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Figure 2 Determinants of T cell fate.  
Environmental factors, protein stability, epigenetics, signaling, transcription, post-
transcriptional gene regulation and metabolism can influence T cell fate decisions. 
 
This introduction will focus on one determinant of T cell fate decision, the RNA-binding 
protein Roquin that post-transcriptionally regulates gene expression to control CD4+ T cell 
differentiation and protects against autoimmunity.  
 The importance of Roquin in the prevention of autoimmune diseases was discovered 
in an ethylnitrosourea (ENU) mutagenesis screen in mice. It identified a single point mutation 
in the Rc3h1 gene, encoding the Roquin-1 protein that causes a lupus-like autoimmune 
disease in homozygous so-called sanroque mice (Vinuesa et al., 2005). These mice carry a 
M199R mutation in the ROQ domain of Roquin-1 and are characterized by an accumulation 
of Tfh cells, which promote the spontaneous formation of germinal centers (GC) where they 
provide inappropriate help to B cells, stimulating the generation of GC B cells and the 
development of high-affinity anti-nuclear autoantibodies (Linterman et al., 2009; Vinuesa et 
al., 2005). Further investigations of Roquin-1 and its paralog Roquin-2 have also shown that 
combined deletion of Roquin-1 and Roquin-2 encoding genes in CD4+ T cells (DKOT mice) 
causes autoinflammatory diseases and leads to spontaneous activation of CD4+ and CD8+ T 
cells. CD4+ T cells in this mouse model adopt a pro-inflammatory Th17 phenotype and 
accumulate in the lung and are more prone to become Tfh cells. Both subsets are likely to 
contribute to the pathology of the DKOT mice (Jeltsch et al., 2014; Vogel et al., 2013). 
Currently, the pronounced T cell phenotype of the sanroque and the DKOT mouse is 
explained by the post-transcriptional derepression of several Roquin-targeted mRNAs, 
leading to an increase in their expression and thereby influencing T cell differentiation. In 
particular elevated mRNA and protein levels of the co-stimulatory receptors ICOS and OX40 
and the Th17 promoting factors IκBNS and IκBzeta, encoded by Nfkbid and Nfkbiz, 
respectively, were found to be involved in the manifestation of the phenotype (Jeltsch et al., 
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2014; Pratama et al., 2013; Vinuesa et al., 2005; Vogel et al., 2013; Yu et al., 2007). On the 
molecular level, several publications have demonstrated that Roquin post-transcriptionally 
controls its targets by recruiting the mRNA decay machinery (Glasmacher et al., 2010; 
Leppek et al., 2013; Murakawa et al., 2015; Sgromo et al., 2017). So far, Roquin function 
was only investigated with respect to its function in mRNA degradation. However, it remained 
elusive if Roquin uses other regulatory mechanisms to control its targets and thereby 
regulates CD4+ T cell differentiation. Furthermore, it is of great interest to identify new 
Roquin-targeted mRNAs to obtain closer insights how Roquin influences T cell fate decisions 
by targeting different mRNAs. Taken together, the focus of this study was centered on 
investigations of new post-transcriptional mechanisms and targets by which Roquin can 
maintain T cell homeostasis and prevent autoimmune and autoinflammatory diseases. 
The first aim of my work was to investigate whether translational regulation is a further 
mechanism that is exerted by Roquin to regulate its targets. The idea of this analysis arose 
from some pre-experiments performed in our laboratory, which hinted to a possible 
translational regulation of Roquin-targeted mRNAs. To test this hypothesis on a global scale, 
I established two state-of-the art methods, namely PAR-CLIP (Photoactivatable 
ribonucleoside crosslinking and immunoprecipitation) and ribosome profiling in mouse 
embryonic fibroblast (MEF) cells. PAR-CLIP was the ideal method to identify transcriptome-
wide binding sites of Roquin and hence to define a Roquin-bound mRNA target set. 
Furthermore, this analysis resulted in the discovery of the first linear sequence element, the 
so-called LBE, that is directly bound via the ROQ and zinc finger (Znf) domains of Roquin 
(Publication I). This finding was unexpected, because several studies proved that Roquin 
mainly binds to stem-loop structures in the 3' untranslated region (UTR) of its targets. These 
hairpins consist of tri- or hexa-loops, also known as constitutive (CDE) or alternative decay 
elements (ADE), respectively, which are recognized by the ROQ domain in a more structure- 
and less sequence-dependent manner. In principle, CDEs are characterized by a pyrimidine-
purine-pyrimidine (Py-Pu-Py) sequence, and ADEs have uridine-rich sequences in their 
loops (Codutti et al., 2015; Janowski et al., 2016; Leppek et al., 2013; Murakawa et al., 2015; 
Sakurai et al., 2015; Schlundt et al., 2014; Schuetz et al., 2014; Tan et al., 2014). 
Interestingly, the core of the LBE sequence is also composed of a Py-Pu-Py order that is 
exclusively recognized by the ROQ domain, whereas the Znf domain recognizes the flanking 
regions preferentially enriched in uridines. However, it has not yet been clarified if the 
recognition of the LBE contributes to the regulatory function of Roquin (Publication I). 
Moreover, we also detected a lower binding affinity of Roquin to the LBE compared to stem-
loop structures. Nevertheless, the LBE is highly abundant in Roquin-targeted mRNAs and 
possibly sterically more accessible for Roquin, suggesting that the LBE could function as a 
stabilizing cis-element for the potentially less stable but high-affinity stem-loops. 
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 Using the defined Roquin mRNA target set and combining it with the ribosome 
profiling and mRNA sequencing data in MEF cells, we were the first to globally prove that 
Roquin not only destabilizes its mRNA targets, but can also regulate them at the translational 
level. In fact, we identified 96 out of 974 targets, which are translationally repressed by 
Roquin. Remarkably, we found that these targets typically have four or more Roquin-binding 
sites in their 3' UTRs (Publication I). With relevance for CD4+ T cell differentiation I found 
two novel direct Roquin targets in our PAR-CLIP dataset: the kinase SGK1 (serum- and 
glucocorticoid-induced protein kinase 1), and the transcription factor NFAT5 (nuclear factor 
of activated T cells 5) (Publication I). Both targets play a critical role in Th17 cell 
differentiation (Alberdi et al., 2016; Kleinewietfeld et al., 2013; Wu et al., 2013) and might 
contribute to the Th17 phenotype of the DKOT mouse. Interestingly, we found that Nfat5 is a 
translationally regulated Roquin target and contains ten Roquin binding sites in its 3' UTR. 
Furthermore, we focused our analysis on the previously described Roquin target Nfkbid, 
which is also essential for Th17 cell generation and function, but also for the development of 
Treg cells in the thymus (Annemann et al., 2015; Kobayashi et al., 2014; Schuster et al., 
2012). However, because Nfkbid is lowly expressed in MEF cells, I performed ribosome 
profiling with a reporter system containing its 3' UTR, thereby identifying Nfkbid as a further 
potential translationally regulated Roquin target. Additionally, polysome profiles of 
endogenous Nfkbid substantiated this finding. Moreover, we identified six stem-loop 
structures within the 3' UTR of Nfkbid, which are crucial for its post-transcriptional regulation 
by Roquin (Publication I).  
 Surprisingly, through further exploration of the ribosome profiling data, I discovered a 
strong downregulation of the translation efficiency of mRNAs encoding for components of the 
translation machinery, such as ribosomal proteins, elongation factors as well as several 
initiation factors. These mRNAs are also known as 5' TOP mRNAs, that are defined by an 
oligopyrimidine tract at their 5' termini, the 5' TOP motif, which is crucial for their translational 
control (Avni et al., 1994; Levy et al., 1991). In addition, we revealed that Roquin also 
negatively impacts on global protein synthesis. This type of regulation was a completely new 
aspect of Roquin-mediated post-transcriptional gene regulation that I did not only find in MEF 
cells, but also in CD4+ T cells (Publication II). Previous studies have already shown that 
primary CD4+ Foxp3– and CD4+ Foxp3+ T cells largely differ in their translational activity to 
determine their cell fate (Bjur et al., 2013). These investigations led us to the assumption that 
Roquin, in addition to regulating individual targets, might also control the overall translational 
machinery to direct CD4+ T cell differentiation. To date, there is only one study showing that 
the translational regulation of TOP mRNAs can affect CD8+ T cell differentiation (Araki et al., 
2017). Nevertheless, we first wanted to investigate how Roquin post-transcriptionally 
regulates TOP mRNAs and initially thought that Roquin directly binds to the TOP motif. 
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However, the PAR-CLIP data did not indicate any Roquin binding sites in the TOP mRNAs, 
suggesting that Roquin indirectly controls the translation of TOP mRNAs. However, I found 
that the ROQ domain and therefore Roquin binding is indispensable for the inhibitory effect 
on protein synthesis (Publication II). A closer look into the literature pointed out that the 
translation of 5' TOP mRNAs is mainly controlled by the mechanistic target of rapamycin 
(mTOR) (Hsieh et al., 2012; Thoreen et al., 2012), and this fact prompted me to investigate 
whether Roquin impacts the PI3K-Akt-mTOR signaling pathway (Publication II).  
mTOR is a serine/threonine kinase that regulates various cellular processes like 
growth, survival, proliferation, metabolism, translation, and cell differentiation. Especially in T 
cells, mTOR integrates a variety of environmental cues such as growth factors, nutrients, 
cytokines, co-stimulation, and TCR signals to translate them into distinct T cell fate decisions 
(Chapman and Chi, 2015; Chi, 2012; Pollizzi and Powell, 2015; Saxton and Sabatini, 2017). 
Over the last few years, several publications have revealed the importance of the PI3K-Akt-
mTOR signaling pathway for the regulation of CD4+ T cell differentiation into the different 
subsets (Delgoffe et al., 2009; Delgoffe et al., 2011; Kurebayashi et al., 2012; Lee et al., 
2010; Ray et al., 2015; Sauer et al., 2008; Xu et al., 2017; Yang et al., 2016b; Yang et al., 
2013; Zeng et al., 2016; Zeng et al., 2013). The results of these studies lead us to speculate 
that Roquin might regulate this pathway to control CD4+ T cell differentiation. To address this 
issue, I first investigated the phosphorylation levels of important downstream substrates of 
the mTOR complexes, mTORC1 and mTORC2, and disclosed that their activities are 
increased in Roquin-deficient CD4+ T cells (Publication II). Interestingly, in the PAR-CLIP 
data set from publication I, I found the phosphatase Pten as a novel direct Roquin target, 
which functions upstream of mTORC1 and mTORC2 and inhibits the activation of the PI3K-
Akt-mTOR pathway. Moreover, it is described that the loss of Pten in T cells results in 
constitutive mTOR activation, thereby increasing Tfh cell differentiation (Zeng et al., 2016) 
and causing dysfunction and instability of Treg cells (Huynh et al., 2015; Shrestha et al., 
2015). Remarkably, the lack of Roquin in CD4+ T cells elicited a reduction of the mRNA and 
protein levels of Pten, an effect that has not yet been observed for any known direct Roquin 
target. In addition, it is known that Pten is also a target of the miR-17~92 cluster, which has 
an important role in the survival, proliferation, differentiation, and function of CD4+ T cells 
(Baumjohann et al., 2013; de Kouchkovsky et al., 2013; Jiang et al., 2011; Kang et al., 2013; 
Liu et al., 2014; Montoya et al., 2017; Simpson et al., 2014; Wu et al., 2015; Xiao et al., 2008; 
Yang et al., 2016a). For this reason, we hypothesized that Roquin might interfere with the 
post-transcriptional repression of Pten by the miR-17~92 cluster, thereby increasing its 
expression. With the help of our PAR-CLIP dataset, we found that Roquin recognizes a 
predicted RNA-stem-loop in the Pten 3' UTR that overlaps with a binding site of the miR-
17~92 cluster (Publication II). Therefore, we supposed that direct binding of Roquin to Pten 
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induces a structural switch within its 3' UTR, and thus impedes the binding of the miR-17~92 
that is loaded into an RNA-induced silencing complex (RISC) (Figure 3). This structural 
change might then prevent miRNA-mediated mRNA decay.  
 
 
 
Figure 3 Model of post-transcriptional regulation of Pten by Roquin. 
Roquin competes with the miR-17~92 RISC complex to prevent miRNA-mediated decay of 
the Pten mRNA.  
 
To prove this model, I performed an Argonaute 2 (Ago2) immunopreciptation in CD4+ T cells 
and analyzed the amount of Pten mRNA associated with Ago2 via quantitative RT-PCR. 
Here, we detected a stronger association of Ago2 with Pten in extracts of Roquin-deficient 
CD4+ T cells compared to control T cells, demonstrating that the RISC complex might bind 
more efficiently to the Pten mRNA when Roquin is not present (Publication II). We have 
thereby uncovered a novel function of Roquin in modulating miRNA-mediated gene 
expression regulation by competing with a miRNA for a common mRNA target. To date the 
existence of such a mechanism could only be shown for one other RNA-binding protein 
named Pumilio, which also induces structural changes in its targeted 3' UTR, but in this case 
to facilitate miRNA-mediated gene silencing (Kedde et al., 2010). 
Since we discovered decreased Pten levels in Roquin-deficient CD4+ T cells, we 
asked whether further downstream substrates of the PI3K-mTOR signaling pathway are 
affected. One substrate of particular interest for us was the transcription factor Foxo1, which 
is an essential regulator for CD4+ T cell differentiation. It positively controls the development 
and function of iTreg cells, but restrains the formation of Tfh and Th17 cells. Upon activation 
of the PI3K-Akt-mTOR signaling pathway Foxo1 is phosphorylated by the kinase Akt and 
exported to the cytoplasm, where it can no longer regulate the transcription of Treg-, Tfh- and 
Th17-related genes (Fabre et al., 2005; Kerdiles et al., 2010; Lainé et al., 2015; Ouyang et 
al., 2010; Ouyang et al., 2012; Stone et al., 2015). In the cytoplasm Foxo1 can be 
ubiquitylated by the E3 ligase Itch promoting its degradation (Xiao et al., 2014). 
Concomitantly with reduced Pten expression in Roquin-deficient CD4+ T cells, we found 
increased activation of Akt, and therefore investigated Foxo1 localization. In fact, we 
observed a stronger translocation of Foxo1 to the cytoplasm. Additionally, we detected 
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increased Foxo1 levels, which coincided with a strong decrease in Itch levels (Publication 
II). Surprisingly, Itch was found in our PAR-CLIP dataset in MEF cells, and in further 
validation experiments I confirmed Itch as a novel direct Roquin target in CD4+ T cells. 
Roquin might repress Itch to enable Foxo1 to relocalize into the nucleus, thereby blocking 
Tfh and Th17 cell differentiation and promoting the generation and function of Treg cells. 
At this point, the question arose whether Roquin indeed regulates the PI3K-Akt-
mTOR-Foxo1 signaling pathway to regulate CD4+ T cell differentiation. In order to shed light 
on this issue, we examined iTreg and Th17 cell differentiation in vitro and Tfh cell 
differentiation in vivo, using different inhibitors against PI3K or mTOR. Strikingly, we obtained 
a rectification of the aberrant frequencies of the three T cell subsets from Roquin-deficient 
mice to levels found in wild-type controls (Publication II). These results clearly demonstrate 
that Roquin suppresses this signaling pathway to control CD4+ T cell differentiation.  
While a dominant role of Roquin in Th17 and Tfh cell differentiation in vivo was 
established, its effect on other CD4+ T cell subsets remained unclear. Based on the fact that 
Treg cells have a pivotal role in the suppression of autoreactive T cells, and that both, the 
sanroque and the DKOT mouse, exhibit signs of autoimmunity and autoinflammation, we 
hypothesized that Roquin might also be involved in Treg cell differentiation and function. 
Hence, it was of great interest to analyze the role of Roquin in Treg cells to obtain a closer 
insight into the mechanism how Roquin protects against autoimmunity. For this analysis, we 
examined Treg cells from mice with a specific deletion of Roquin-1 and Roquin-2 in these 
cells (DKOTreg mice) and revealed that they lose their suppressive activity on Teff cells 
(Publication II). Based on these findings, my aim was to elucidate the molecular mechanism 
how Roquin controls Treg cell function. Interestingly, the extensive investigation of the 
phenotype of the DKOTreg mice showed a strong overlap with the phenotype of mice with a 
Treg-specific deletion of Pten (Pten KOTreg mice). Both phenotypes exhibited increased 
numbers and frequencies of Treg cells, presumably due to a stronger proliferation, enhanced 
activation of CD4+ and CD8+ T cells, loss of Treg function in vivo and development of 
splenomegaly and lymphadenopathy. The phenotype of the Pten KOTreg mouse was 
explained by a strong PI3K-mTORC2 activity in Treg cells (Huynh et al., 2015; Shrestha et 
al., 2015). Moreover, previous studies have demonstrated that both mTOR complexes 
negatively impact Treg cell differentiation and indicated that both complexes must be inactive 
to allow Treg cell differentiation (Delgoffe et al., 2009; Delgoffe et al., 2011; Sauer et al., 
2008). However, a further study showed that the suppressive activity of Treg cells mainly 
relies on mTORC1 signaling (Zeng et al., 2013). Taken together, these findings convinced 
me to investigate the PI3K-Akt-mTOR signaling pathway in Treg cells. Firstly, I analyzed 
again mTORC1 and mTORC2 activity by examining the phosphorylation levels of their 
downstream substrates, and herein I detected increased activity of both complexes in 
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Roquin-deficient Treg cells. In addition, as already shown for CD4+ T cells, Pten levels were 
downregulated and Itch levels were upregulated in Roquin-deficient Treg cells demonstrating 
that the regulation of the PI3K-Akt-mTOR signaling pathway is a central mechanism that 
Roquin also uses to control Treg cell differentiation and function (Publication II).  
Interestingly, when we analyzed the DKOTreg mice, we observed a strong 
accumulation of Tfr cells. This CD4+ T cell subset was initially discovered a few years ago, 
and since then several studies have focused on the elucidation of their development and 
function, which have not yet been fully clarified. So far, it is known that Tfr cells develop from 
thymus-derived Foxp3+ Treg precursor cells (Figure 1) and resemble Tfh and Treg cells 
phenotypically by the coexpression of Tfh and Treg signature markers. However, in contrast 
to Tfh cells, Tfr cells suppress GC responses by inhibiting Tfh and GC B cells (Chung et al., 
2011; Linterman et al., 2011; Wollenberg et al., 2011). Furthermore, differentiation and 
function of Tfr cells require mTORC1 activity (Xu et al., 2017). First of all, we were interested 
if the arising Tfr cells in the DKOTreg mice are functional in inhibiting GC reactions. Therefore, 
I immunized wild-type and DKOTreg mice with an antigen to induce an immune response and 
found that only a few antigen-specific GC B cells were formed in the DKOTreg compared to 
wild-type mice (Publication II). Furthermore, we observed that Roquin-deficient Treg cells 
strongly down-regulated the expression of the α-chain of the IL-2 receptor (CD25). In 
general, IL-2 is essential for Treg cell development, maintenance and function (Cheng et al., 
2013; Chinen et al., 2016; de la Rosa et al., 2004; Fontenot et al., 2005). To elucidate the 
mechanism of Roquin in restraining CD25 expression on Treg cells on the molecular level, I 
performed mRNA sequencing to compare mRNA expression of CD25+ and CD25- Roquin-
deficient Treg cells. Surprisingly, we found that CD25- Roquin-deficient Treg cells strongly 
express Tfh signature genes, whereas CD25+ Roquin-deficient Treg cells still express Treg 
signature genes (Publication II). From these results we concluded that Roquin-deficient 
Treg cells that lose CD25 are no longer sensitive to IL-2 and can therefore convert into Tfr 
cells and suppress GC immune responses. During the revision of our publication two other 
studies also came up with the finding that Tfr cells do not express CD25 because ongoing IL-
2 signaling limits their differentiation (Botta et al., 2017; Wing et al., 2017). Nevertheless, we 
were the first to connect increased mTORC1 and mTORC2 activity in Treg cells to CD25 
downregulation, and thereby to the generation of Tfr cells in a Roquin-dependent manner.  
In conclusion, in this thesis I identified novel post-transcriptional mechanisms that 
Roquin exerts to maintain T cell homeostasis and to prevent autoimmune and 
autoinflammatory diseases. In particular I elucidated that Roquin does not only destabilize its 
mRNA targets but also represses their translation. Furthermore, I proved that Roquin 
suppresses the PI3K-Akt-mTOR-Foxo1 pathway to control CD4+ T cell differentiation. The 
multiple layers on which Roquin mediates its regulatory effect on differentiation are good 
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examples for the complexity of T cell fate decisions and its fragile nature. The absence of a 
functional Roquin protein in both the sanroque and the DKOT mouse results in a tilted 
immune balance towards inflammation. A broader understanding of the determinants of T 
cell fate decisions in vivo is required to understand how dysregulated immune responses 
arise and how they could be controlled. 
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3 Publication I 
 
DOI  https://doi.org/10.1038/s41467-018-06184-3 
 
Roquin targets mRNAs in a 3'-UTR-specific manner by different 
modes of regulation 
 
Katharina Essig, Nina Kronbeck, Joao C. Guimaraes, Claudia Lohs, Andreas Schlundt, 
Anne Hoffmann, Gesine Behrens, Sven Brenner, Joanna Kowalska,  
Cristina Lopez-Rodriguez, Jacek Jemielity, Helmut Holtmann, Kristin Reiche,  
Jörg Hackermüller, Michael Sattler, Mihaela Zavolan, and Vigo Heissmeyer 
 
3.1 Contribution to the publication 
As a first author of this publication, I was deeply involved in the conception of this study, 
performed the main body of the experimental work and wrote the manuscript together with 
the two corresponding authors Mihaela Zavolan and Vigo Heissmeyer. A central part of my 
work was to establish and perform two state-of-the art methods: PAR-CLIP and ribosome 
profiling. The data sets from these techniques enabled us to define a Roquin target mRNA 
set in MEF cells (Fig. 1a-d and Fig. S1), and by combining them with mRNA sequencing data 
to globally dissolve translational regulation of Roquin-targeted mRNAs (Fig. 7d-e). The 
bioinformatic analysis was performed by Joao Guimaraes. Additionally, I investigated the 
regulation of the Roquin targeted 3' UTR of Nfkbid in ribosome profiles of MEF cells (Fig.2d 
and Fig.6a) and analyzed this 3' UTR as well as mutant forms in degradation kinetic studies 
and polysome profiles using a β-globin reporter system in HeLa cells (Fig. 7 a-c and 
Supplementary S6 i). Furthermore, I reanalyzed the polysome profiling data generated by our 
collaboration partners and compared subpolysomal with polysomal fractions to prove 
translational regulation of endogenous Nfkbid by Roquin in MEF and CD4+ T cells (Fig. 6c, e 
and Fig. S6g). To examine Roquin-mediated mRNA decay in more detail, I also generated 
and tested a MEF cell line expressing a doxycycline-inducible shRNA against the core 
subunit of the deadenylase complex cNOT1 (Fig. 5k). Finally, I identified two novel Roquin 
targets, Sgk1 and Nfat5, and validated these targets by investigating Roquin-dependent 
regulation in reporter assays as well as on the mRNA and protein level (Fig. 8d-j and Fig. 
S7d-e). 
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4 Publication II 
 
DOI  https://doi.org/10.1016/j.immuni.2017.11.008 
 
Roquin suppresses the PI3K-mTOR signaling pathway to inhibit 
T helper cell differentiation and conversion of Treg to Tfr cells 
 
Katharina Essig, Desheng Hu, Joao C. Guimaraes, Dominik Alterauge, Stephanie Edelmann, 
Timsse Raj, Jan Kranich, Gesine Behrens, Alexander Heiseke, Stefan Floess, Juliane Klein, 
Andreas Maiser, Susan Marschall, Martin Hrabĕ de Angelis, Heinrich Leonhardt, 
 Cornelis F. Calkhoven, Elfriede Noessner, Thomas Brocker, Jochen Huehn, Anne B. Krug,  
Mihaela Zavolan, Dirk Baumjohann, and Vigo Heissmeyer 
 
4.1 Contribution to the publication 
As a first author of this publication, I made major contributions to the experimental work as 
well as to the conception of the study. Furthermore, I wrote the manuscript together with the 
two corresponding authors Desheng Hu and Vigo Heissmeyer. Initially, through a thorough 
analysis of the mRNA-sequencing and ribosome profiling data from publication I, I found that 
Roquin indirectly downregulates the translation of 5' TOP mRNAs and thereby restricts the 
overall protein synthesis in MEF and CD4+ T cells (Fig. 5A-C and Fig. S5A-D). According to 
the literature it is known that the translation of 5' TOP mRNAs is mainly controlled by the 
kinase mTOR, and this finding prompted me to investigate the impact of Roquin on the PI3K-
mTOR signaling pathway (Fig. 5D-F and Fig. S6A-C). Herein, I disclosed that Roquin 
suppresses this pathway by regulating its direct targets PTEN and Itch in conventional T and 
Treg cells (Fig. 5I-K, Fig. 6B-E and Fig. S6D-E, G). In addition, I elucidated the mechanism 
how Roquin post-transcriptionally regulates Pten mRNA expression (Fig. 6H-I). Moreover, I 
had the idea to investigate whether the aberrant numbers of Th17, Treg and Tfh cells in mice 
with a T cell specific deletion of Roquin-1 and Roquin-2 can be corrected to levels found in 
wild-type counterparts through the inhibition of PI3K or mTOR in vitro and in vivo. To show 
this, I performed several experiments by myself (Fig. 7B,D and Fig. S7A-C, E) and I also 
strongly supported my colleagues for their analyses (Fig. 7G-M and Fig. S7F-M). 
Furthermore, I investigated the function of Tfr cells in suppressing germinal center responses 
(Fig. 2G-I and Fig. S1I-J) and examined the conversion of Treg into Tfr cells on the mRNA 
and protein level (Fig. 3C, E-F and Fig. S4F-G). Additionally, I contributed to the experiments 
performed by our collaboration partners. I provided and prepared cells for the analysis of 
cytokines (Fig. S4A-E) and Foxo1 localization (Fig. 5G-H, CD4+ T cells), immunized mice 
and collected blood samples to study antibody affinity maturation (Fig. 2J-M), and sorted 
Treg cells for the in vitro suppression assay (Fig. S2A-B). 
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